Papillon Patients in Phase III Opera Trial
The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.
Phase III Clinical Trial OPERA starts
The Organ Preservation of Early Rectal Adenocarcinoma (OPERA) phase III trial has started to recruit patients at the Centre Antoine-Lacassagne in Nice, France. This Pan-European trial, developed by Prof Jean-Pierre Gerard (Nice) and Prof Arthur Sun Myint (Clatterbridge, UK) is looking to recruit patients across existing Papillon users in France, UK, Sweden, Denmark and Switzerland as well as driving interest in new territories.